| Ausstehende Aktien | 46,588,709 shares |
| Insider-Aktien | 5.401.084 shares |
| Insider-Besitz | 11,59 % |
| Insider gesamt | 32 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
5150 out of 10752
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Minerva Neurosciences, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Frederick W Ahlholm SVP, CFO and Secretary - [O] | 17.518 | 17.518 | |
|
Plc Barclays
10% Owner -
|
196.800 | 196.800 | |
|
Boehringer Ingelheim International Gmbh
10% Owner -
|
2.550.000 | 2.550.000 | |
| Marc D Beer Director - [D] | 50.000 | 6.250 | |
|
Care Capital III LLC
10% Owner -
|
1.662.592 | 207.824 | |
|
Care Capital Investments III L.P.
10% Owner -
|
1.662.592 | 207.824 | |
|
Care Capital Offshore Investments III LP
10% Owner -
|
1.662.592 | 207.824 | |
| William F Doyle Director - [D] | 26.111 | 3.264 | |
| Michael Davidson Chief Medical Officer - [O] | 0 | 0 | |
|
Rubertis Francesco De
Director, 10% Owner -
[D]
|
4.690.906 | 586.363 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Hans Peter Hasler Director - [D] | 10.000 | 1.250 | |
| Jeryl L Hilleman Director - [D] | 1.000 | 125 | |
|
Venture Associates III Ltd Index
10% Owner -
|
3.899.189 | 487.399 | |
|
Venture Associates IV Ltd Index
10% Owner -
|
3.899.189 | 487.399 | |
|
Venture Associates V Ltd Index
10% Owner -
|
3.899.189 | 487.399 | |
|
& Johnson Johnson
10% Owner -
|
0 | 0 | |
|
Johnson & Johnson Innovation - JJDC, Inc.
10% Owner -
|
0 | 0 | |
| David Kupfer Director - [D] | 163.553 | 20.444 | |
| Fouzia Laghrissi-Thode Director - [D] | 0 | 0 | |
| Levine Mark S. SVP,General Counsel & Sec. - [O] | 0 | 0 | |
| Remy Luthringer CEO, Director - [D] [O] | 184.819 | 184.819 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
|
Michele Ollier
Director, 10% Owner -
[D]
|
4.690.906 | 586.363 | |
|
Lorenzo Pellegrini
Director, 10% Owner -
[D]
|
3.883.212 | 485.402 | |
| Geoff Race President - [O] | 51.324 | 51.324 | |
| Reilly Joseph H. SVP & Chief Operating Officer - [O] | 31.747 | 3.968 | |
| Russell Richard E. President - [O] | 33.770 | 4.221 | |
| Jay Saoud | 100.000 | ||
| Devin Whittemore Smith | 85.000 | ||
| Heek G Jan Van Director - [D] | 20.333 | 2.542 | |
| Nico Vandervelpen Director - [D] | 0 | 0 | |
| Coelho Rogerio Vivaldi President and CEO, Director - [D] [O] | 41.667 | 5.208 | |
|
(Jersey) SLP Yucca
10% Owner -
|
3.899.189 | 487.399 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in NERV / Minerva Neurosciences, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in NERV / Minerva Neurosciences, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-07 | 3 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | NERV | Common Stock | D | 1.275.000 | ||||||||
| 2023-05-02 | 2023-05-02 | 4 | Luthringer Remy | NERV | Common Stock | D | 3,7600 | -3.641 | -14 | 68.994 | ||||
| 2023-05-02 | 2023-05-01 | 4 | Luthringer Remy | NERV | Common Stock | D | 3,8500 | -23.753 | -91 | 72.635 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Luthringer Remy | NERV | Common Stock | D | 88.077 | 96.388 | ||||||
| 2023-05-02 | 2023-05-01 | 4 | Race Geoff | NERV | Common Stock | D | 3,8500 | -22.082 | -85 | 51.324 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Race Geoff | NERV | Common Stock | D | 46.987 | 73.406 | ||||||
| 2023-05-02 | 2023-05-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,4800 | -3.580 | -16 | 17.518 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 19.843 | 21.098 | ||||||
| 2022-08-10 | 3 | BARCLAYS PLC By Barclays Capital Inc. | NERV | Common Stock, $0.0001 par value per share | I | 196.800 | ||||||||
| 2022-08-10 | 3 | BARCLAYS PLC By Barclays Bank PLC | NERV | Common Stock, $0.0001 par value per share | I | 408.430 | ||||||||
| 2022-02-18 | 2022-02-16 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 0,79 | 180.000 | 180.000 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 0,79 | 505.000 | 505.000 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 0,79 | 200.000 | 200.000 | |||||
| 2021-12-03 | 2021-12-01 | 4 | Kupfer David | NERV | Common Stock | D | 0,8800 | -55.635 | -49 | 163.553 | ||||
| 2021-06-16 | 2021-06-11 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 2,90 | 40.000 | 40.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2020-12-16 | 2020-12-16 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 2,6400 | -3.228 | -9 | 31.747 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8.750 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8.750 | 34.975 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Race Geoff | NERV | Common Stock | D | 2,6400 | -6.190 | -16 | 211.354 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12.500 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12.500 | 217.544 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Luthringer Remy | NERV | Common Stock | D | 2,6400 | -1.300 | -3 | 66.490 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18.750 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18.750 | 67.790 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 2,6400 | -1.845 | -5 | 10.039 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5.000 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.000 | 11.884 | ||||||
| 2020-10-14 | 2020-10-13 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 3,50 | 200.000 | 200.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 3,50 | 140.000 | 140.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85.000 | 85.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85.000 | 85.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 3,50 | 100.000 | 100.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85.000 | 85.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85.000 | 85.000 | |||||
| 2020-09-11 | 2020-09-10 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 2,9700 | 7.000 | 21 | 20.333 | ||||
| 2020-08-17 | 2020-06-19 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,11 | 153.531 | 153.531 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,11 | 275.568 | 275.568 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,11 | 137.784 | 137.784 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,11 | 354.302 | 354.302 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 153.531 | 153.531 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 185.025 | 185.025 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,11 | 236.202 | 236.202 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,11 | 137.784 | 137.784 | |||||
| 2020-06-12 | 2020-06-11 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 3,40 | 40.000 | 40.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-05-27 | 2020-05-26 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 15,0000 | -8.339 | -125 | 6.884 | ||||
| 2020-01-03 | 2019-12-31 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,11 | 74.432 | 74.432 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 41.469 | 41.469 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 49.975 | 49.975 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,11 | 63.798 | 63.798 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,11 | 41.469 | 41.469 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,11 | 37.216 | 37.216 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,11 | 37.216 | 37.216 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,11 | 95.698 | 95.698 | |||||
| 2019-12-17 | 2019-12-17 | 4 | Race Geoff | NERV | Common Stock | D | 7,1000 | -5.826 | -41 | 205.044 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12.500 | 12.500 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12.500 | 210.870 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 7,1000 | -2.724 | -19 | 26.225 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8.750 | 8.750 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8.750 | 28.949 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 7,1000 | -1.557 | -11 | 15.223 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5.000 | 5.000 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.000 | 16.780 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Luthringer Remy | NERV | Common Stock | D | 7,1000 | -2.412 | -17 | 49.040 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18.750 | 18.750 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18.750 | 51.452 | ||||||
| 2019-12-13 | 2019-12-12 | 4 | Russell Richard E. | NERV | Common Stock | D | 7,4200 | -3.113 | -23 | 33.770 | ||||
| 2019-07-01 | 2019-06-27 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 5,5000 | 3.500 | 19 | 26.111 | ||||
| 2019-06-27 | 2019-06-26 | 4 | Kupfer David | NERV | Common Stock | D | 5,5500 | 10.000 | 56 | 219.188 | ||||
| 2019-06-27 | 2019-06-26 | 4 | HASLER HANS PETER | NERV | Common Stock | D | 5,6000 | 10.000 | 56 | 10.000 | ||||
| 2019-06-27 | 2019-06-26 | 4 | HILLEMAN JERYL L | NERV | Common Stock | D | 5,2500 | 1.000 | 5 | 1.000 | ||||
| 2019-06-27 | 2019-06-26 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 5,3700 | 10.000 | 54 | 13.333 | ||||
| 2019-06-26 | 2019-06-24 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0144 | -197.000 | -1.185 | 3.899.189 | ||||
| 2019-06-21 | 2019-06-20 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,3413 | -33.575 | -146 | 4.096.189 | ||||
| 2019-06-21 | 2019-06-19 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4425 | -77.243 | -343 | 4.129.764 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4393 | -49.675 | -221 | 4.207.007 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4487 | -56.243 | -250 | 4.256.682 | ||||
| 2019-06-17 | 2019-06-14 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4971 | -25.169 | -113 | 4.312.925 | ||||
| 2019-06-17 | 2019-06-13 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,5133 | -53.298 | -241 | 4.338.094 | ||||
| 2019-06-13 | 2019-06-12 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,5719 | -26.901 | -123 | 4.391.392 | ||||
| 2019-06-13 | 2019-06-11 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,7769 | -33.150 | -158 | 4.418.293 | ||||
| 2019-06-13 | 2019-06-12 | 4 | DOYLE WILLIAM F | NERV | Stock option (right to buy) | D | 4,50 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-21 | 2019-05-20 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0750 | -200 | -1 | 4.451.443 | ||||
| 2019-05-21 | 2019-05-17 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0164 | -22.718 | -137 | 4.451.643 | ||||
| 2019-05-16 | 2019-05-16 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,3715 | -44.836 | -286 | 4.474.361 | ||||
| 2019-05-16 | 2019-05-15 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,6357 | -53.418 | -354 | 4.519.197 | ||||
| 2019-05-16 | 2019-05-14 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 7,0548 | -36.574 | -258 | 4.572.615 | ||||
| 2018-12-26 | 2018-12-20 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 6,5000 | 2.000 | 13 | 22.611 | ||||
| 2018-12-18 | 2018-12-17 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 7,4600 | -2.728 | -20 | 20.199 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8.750 | 17.500 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8.750 | 22.927 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Luthringer Remy | NERV | Common Stock | D | 7,4600 | -2.604 | -19 | 32.702 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18.750 | 37.500 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18.750 | 35.306 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 7,4600 | -1.559 | -12 | 11.780 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5.000 | 10.000 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.000 | 13.339 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Race Geoff | NERV | Common Stock | D | 7,4600 | -5.999 | -45 | 198.370 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12.500 | 25.000 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12.500 | 204.369 | ||||||
| 2018-12-13 | 2018-12-12 | 4 | Russell Richard E. | NERV | Common Stock | D | 7,9600 | -3.117 | -25 | 36.883 | ||||
| 2018-12-13 | 2018-12-11 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,96 | 260.000 | 260.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,96 | 96.000 | 96.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120.000 | 120.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120.000 | 120.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,96 | 175.000 | 175.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,96 | 410.000 | 410.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,96 | 175.000 | 175.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120.000 | 120.000 | |||||
| 2018-12-12 | 2018-12-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 7,9500 | 4.000 | 32 | 20.611 | ||||
| 2018-12-12 | 2018-12-10 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 8,0000 | 2.000 | 16 | 16.611 | ||||
| 2018-11-21 | 2018-11-20 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 8,2000 | 2.000 | 16 | 14.611 | ||||
| 2018-10-15 | 2018-10-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,0000 | 600 | 6 | 12.611 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | -10.000 | 47.524 | |||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | -15.000 | 27.400 | |||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,6200 | -1.700 | -21 | 14.177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,0200 | -23.300 | -280 | 15.877 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 5,1900 | 10.000 | 52 | 39.177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 15.000 | 71 | 29.177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,3509 | -15.444 | -191 | 4.609.189 | ||||
| 2018-10-01 | 2018-09-28 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,6151 | -34.589 | -436 | 4.624.633 | ||||
| 2018-10-01 | 2018-09-27 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,5702 | -31.684 | -398 | 4.659.222 | ||||
| 2018-09-19 | 2018-09-17 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 1.800 | 19 | 12.011 | ||||
| 2018-09-17 | 2018-09-14 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 200 | 2 | 10.211 | ||||
| 2018-09-17 | 2018-09-13 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 2.000 | 21 | 10.011 | ||||
| 2018-09-11 | 2018-09-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 9,7200 | 4.011 | 39 | 8.011 | ||||
| 2018-09-11 | 2018-09-10 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 9,8800 | 4.000 | 40 | 4.000 | ||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | -25.000 | 42.400 | |||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 10,0000 | -25.000 | -250 | 14.177 | ||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 25.000 | 118 | 39.177 | ||||
| 2018-08-02 | 2018-08-01 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (Righ to Buy) | D | 7,95 | 200.000 | 200.000 | |||||
| 2018-08-02 | 2018-08-01 | 4 | DOYLE WILLIAM F | NERV | Stock Option (Right to Buy) | D | 7,95 | 20.000 | 20.000 | |||||
| 2018-07-17 | 2018-07-16 | 4 | HILLEMAN JERYL L | NERV | Stock Option (Right to Buy) | D | 8,20 | 40.000 | 40.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | DOYLE WILLIAM F | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | HASLER HANS PETER | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Kupfer David | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | -12.500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,20 | -12.500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 4,34 | 7.500 | 7.500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 4,34 | -7.500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | 127.513 | 127.513 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | -127.513 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 9,49 | 80.356 | 80.356 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 9,49 | -80.356 | 0 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,20 | 200.000 | 200.000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12.500 | 37.500 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 5,7900 | -5.829 | -34 | 191.869 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12.500 | 197.698 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 200.000 | 200.000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Saoud Jay | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 175.000 | 175.000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Davidson Michael | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 125.000 | 125.000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5.000 | 15.000 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,8000 | -1.661 | -10 | 8.339 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.000 | 10.000 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 120.000 | 120.000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8.750 | 26.250 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 5,8000 | -2.906 | -17 | 14.177 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8.750 | 17.083 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 120.000 | 120.000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18.750 | 56.250 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 5,8500 | -2.194 | -13 | 16.556 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18.750 | 18.750 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 350.000 | 350.000 | |||||
| 2017-12-12 | 2017-12-10 | 4 | DOYLE WILLIAM F | NERV | Option Grant (Right to Buy) | D | 5,70 | 40.000 | 40.000 | |||||
| 2017-12-12 | 2017-12-10 | 4 | HASLER HANS PETER | NERV | Option Grant (Right to Buy) | D | 5,70 | 40.000 | 40.000 | |||||
| 2017-12-12 | 2017-12-11 | 4 | Russell Richard E. | NERV | Employee Stock option (Right to Buy) | D | 6,05 | 775.000 | 775.000 | |||||
| 2017-12-12 | 2017-12-11 | 4 | Russell Richard E. | NERV | Common Stock | D | 40.000 | 40.000 | ||||||
| 2017-09-14 | 2017-08-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 0,0001 | -3.892.256 | -0 | 0 | ||||
| 2017-09-05 | 2017-09-01 | 4 | Saoud Jay | NERV | Employee Stock Option (Right to Buy) | D | 6,45 | 100.000 | 100.000 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | -12.500 | 0 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,20 | -12.500 | 0 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 4,71 | 25.000 | 25.000 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 4,71 | -25.000 | 0 | |||||
| 2017-06-05 | 2017-06-01 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | -7.250 | 49.750 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | -14.381 | 43.143 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 11,0000 | -10.381 | -114 | 5.000 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 10,0000 | -11.250 | -112 | 15.381 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,7100 | 7.250 | 34 | 26.631 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,1900 | 14.381 | 75 | 19.381 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Kupfer David | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | -17.500 | 39.774 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Common Stock | D | 11,0000 | -17.500 | -192 | 0 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Common Stock | D | 5,1900 | 17.500 | 91 | 17.500 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-03-21 | 2017-03-20 | 4 | Beer Marc D | NERV | Common Stock | D | 7,8900 | 25.000 | 197 | 50.000 | ||||
| 2017-03-21 | 2017-03-17 | 4 | Beer Marc D | NERV | Common Stock | D | 8,3400 | 25.000 | 208 | 25.000 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 4,71 | -2.185 | 285.719 | |||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Common Stock | D | 11,0000 | -2.185 | -24 | 0 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Common Stock | D | 4,7100 | 2.185 | 10 | 2.185 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 4,71 | -32.096 | 287.904 | |||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Common Stock | D | 11,0200 | -32.096 | -354 | 0 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Common Stock | D | 4,7100 | 32.096 | 151 | 32.096 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Race Geoff | NERV | Common Stock | D | 11,0000 | -1.692 | -19 | 185.198 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Race Geoff | NERV | Common Stock | D | 11,0200 | -19.758 | -218 | 186.890 | ||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Stock Option (Right to Buy) | D | 4,71 | -1.600 | 67.400 | |||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,0300 | -1.600 | -19 | 8.333 | ||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 1.600 | 8 | 9.933 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Stock Option (Right to Buy) | D | 5,19 | -250 | 57.274 | |||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Stock Option (Right to Buy) | D | 4,71 | -17.250 | 51.750 | |||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 12,0000 | -17.500 | -210 | 0 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 5,1900 | 250 | 1 | 17.500 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 4,7100 | 17.250 | 81 | 17.250 | ||||
| 2017-01-05 | 2017-01-03 | 4 | Davidson Michael | NERV | Stock Option (Right to Buy) | D | 11,75 | 145.000 | 145.000 | |||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | -12.000 | 57.000 | |||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 12,5100 | -17.000 | -213 | 5.000 | ||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,7100 | 12.000 | 57 | 22.000 | ||||
| 2016-12-20 | 3 | Davidson Michael | NERV | Common Stock | D | 0 | ||||||||
| 2016-12-16 | 2016-12-14 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 35.000 | 35.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | 20.000 | 20.000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 100.000 | 100.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | 50.000 | 50.000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 13,45 | 150.000 | 150.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | 75.000 | 75.000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 60.000 | 60.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | 35.000 | 35.000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 35.000 | 35.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Levine Mark S. | NERV | Restricted Stock Units | D | 20.000 | 20.000 | ||||||
| 2016-12-14 | 2016-12-12 | 4 | Ollier Michele See Footnotes | NERV | Warrant Shares | I | 5,77 | -202.634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 5,7720 | 202.634 | 1.170 | 4.690.906 | ||||
| 2016-12-14 | 2016-12-12 | 4 | De Rubertis Francesco See Footnotes | NERV | Warrant Shares | I | 5,77 | -202.634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 5,7720 | 202.634 | 1.170 | 4.690.906 | ||||
| 2016-12-14 | 2016-12-12 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Warrant Shares | I | 5,77 | -202.634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 5,7720 | 202.634 | 1.170 | 4.690.906 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 10,0000 | -1.000.000 | -10.000 | 4.488.272 | ||||
| 2016-08-12 | 2016-08-10 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 10,0000 | -1.000.000 | -10.000 | 4.488.272 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 10,0000 | -1.000.000 | -10.000 | 4.488.272 | ||||
| 2016-06-21 | 2016-06-21 | 4 | Kupfer David By wife | NERV | Common Stock | I | 10,7250 | 27.935 | 300 | 27.935 | ||||
| 2016-06-21 | 2016-06-20 | 4 | Kupfer David | NERV | Common Stock | D | 10,9530 | 27.700 | 303 | 209.188 | ||||
| 2016-06-17 | 2016-06-16 | 4 | Beer Marc D | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Vandervelpen Nico | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-03-18 | 2016-03-17 | 4 | Kupfer David | NERV | Common Stock | D | 5,5100 | 181.488 | 1.000 | 181.488 | ||||
| 2016-02-12 | 2015-03-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 4,9300 | 607.903 | 2.997 | 3.892.256 | ||||
| 2015-12-08 | 2015-12-04 | 4 | Levine Mark S. | NERV | Stock Option (right to buy) | D | 4,71 | 69.000 | 69.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Reilly Joseph H. | NERV | Stock Option (right to buy) | D | 4,71 | 69.000 | 69.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Race Geoff | NERV | Stock Option (right to buy) | D | 4,71 | 175.000 | 175.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Luthringer Remy | NERV | Stock Option (right to buy) | D | 4,71 | 320.000 | 320.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Ahlholm Frederick W | NERV | Stock Option (right to buy) | D | 4,71 | 69.000 | 69.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Vandervelpen Nico | NERV | Stock Option (right to buy) | D | 4,71 | 25.000 | 25.000 | |||||
| 2015-11-03 | 3 | Kupfer David | NERV | Common Stock | D | 0 | ||||||||
| 2015-11-03 | 3 | Kupfer David | NERV | Common Stock | D | 0 | ||||||||
| 2015-11-03 | 2015-11-02 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 5,41 | 25.000 | 25.000 | |||||
| 2015-06-18 | 2015-06-17 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 25.000 | 25.000 | ||||||
| 2015-05-18 | 3 | Laghrissi-Thode Fouzia | NERV | Common Stock | D | 0 | ||||||||
| 2015-04-16 | 2015-02-02 | 4/A | Beer Marc D | NERV | Stock Option (right to buy) | D | 7.500 | 7.500 | ||||||
| 2015-04-16 | 2015-04-14 | 4 | Ahlholm Frederick W | NERV | Stock Option (right to buy) | D | 5,19 | 57.524 | 57.524 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Race Geoff | NERV | Stock Option (right to buy) | D | 5,19 | 213.133 | 213.133 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Luthringer Remy | NERV | Stock Option (right to buy) | D | 5,19 | 399.623 | 399.623 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Reilly Joseph H. | NERV | Stock Option (right to buy) | D | 5,19 | 57.524 | 57.524 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Levine Mark S. | NERV | Stock Option (right to buy) | D | 5,19 | 57.524 | 57.524 | |||||
| 2015-03-20 | 2015-03-18 | 4 | De Rubertis Francesco See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202.634 | 25 | 202.634 | |||
| 2015-03-20 | 2015-03-18 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 4,8100 | 202.634 | 975 | 5.488.272 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Care Capital III LLC | NERV | Common Stock | I | 6,2500 | -6.700 | -42 | 1.662.592 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,7500 | -1.200.000 | -6.900 | 1.669.292 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Ollier Michele See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202.634 | 25 | 202.634 | |||
| 2015-03-20 | 2015-03-18 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 4,8100 | 202.634 | 975 | 5.488.272 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202.634 | 25 | 202.634 | |||
| 2015-03-20 | 2015-03-18 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 4,8100 | 202.634 | 975 | 5.488.272 | ||||
| 2015-03-17 | 2015-03-13 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation- JJDC, Inc. | NERV | Warrants (right to buy) | I | 5,77 | 0,1250 | 607.903 | 76 | 607.903 | |||
| 2015-03-17 | 2015-03-13 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 4,8100 | 607.903 | 2.924 | 4.500.159 | ||||
| 2015-02-04 | 2015-02-02 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 7.500 | 7.500 | ||||||
| 2015-02-04 | 2015-02-02 | 4 | Beer Marc D | NERV | Stock Option (right to buy) | D | 7.500 | 7.500 | ||||||
| 2015-01-26 | 2015-01-26 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,0200 | -23.111 | -116 | 2.869.292 | ||||
| 2015-01-26 | 2015-01-23 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,1400 | -63.304 | -325 | 2.892.403 | ||||
| 2015-01-26 | 2015-01-22 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,1100 | -395.697 | -2.022 | 2.955.707 | ||||
| 2015-01-08 | 2015-01-08 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,6600 | -70.659 | -400 | 3.351.404 | ||||
| 2015-01-08 | 2015-01-07 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,8500 | -64.278 | -376 | 3.422.063 | ||||
| 2015-01-08 | 2015-01-06 | 4 | Care Capital III LLC | NERV | Common Stock | I | 7,9400 | -396.871 | -3.151 | 3.486.341 | ||||
| 2014-09-03 | 2014-09-02 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 7,10 | 93.541 | 93.541 | |||||
| 2014-09-03 | 3 | Vandervelpen Nico | NERV | No securities are beneficially owned. | D | 0 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6.568.706 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6.568.706 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6.568.706 | ||||||||
| 2014-07-11 | 2014-06-30 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 207.869 | 649.842 | |||||
| 2014-07-11 | 2014-06-30 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 441.973 | 441.973 | |||||
| 2014-07-09 | 2014-06-30 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | 127.513 | 127.513 | |||||
| 2014-07-09 | 2014-07-01 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 6,0000 | 3.333 | 20 | 3.333 | ||||
| 2014-07-09 | 2014-06-30 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 6,00 | 51.967 | 51.967 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 333.333 | 2.000 | 5.285.638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 1.287.500 | 7.725 | 4.952.305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 61.922 | 372 | 3.664.805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 114.077 | 684 | 3.602.883 | ||||
| 2014-07-09 | 2014-07-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 6,0000 | 10.000 | 60 | 10.000 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 93.541 | 93.541 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.923 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.078 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 737.500 | 4.425 | 3.883.212 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 61.923 | 372 | 3.145.712 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 114.078 | 684 | 3.083.789 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 333.333 | 2.000 | 5.285.638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 1.287.500 | 7.725 | 4.952.305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 61.922 | 372 | 3.664.805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 114.077 | 684 | 3.602.883 | ||||
| 2014-07-09 | 2014-07-01 | 4 | Vivaldi Coelho Rogerio | NERV | Common Stock | D | 6,0000 | 41.667 | 250 | 41.667 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Vivaldi Coelho Rogerio | NERV | Employee Stock Option (right to buy) | D | 6,00 | 498.621 | 498.621 | |||||
| 2014-07-09 | 2014-07-01 | 4 | Race Geoff | NERV | Common Stock | D | 6,0000 | 33.333 | 200 | 206.648 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 249.442 | 346.585 | |||||
| 2014-07-09 | 2014-06-30 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 97.143 | 97.143 | |||||
| 2014-07-09 | 2014-07-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 6,0000 | 8.333 | 50 | 8.333 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 93.541 | 93.541 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.923 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.078 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 737.500 | 4.425 | 3.883.212 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 61.923 | 372 | 3.145.712 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 114.078 | 684 | 3.083.789 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 333.333 | 2.000 | 5.285.638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 1.287.500 | 7.725 | 4.952.305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 61.922 | 372 | 3.664.805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 114.077 | 684 | 3.602.883 | ||||
| 2014-06-30 | 3 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Race Geoff | NERV | Common Stock | D | 346.630 | ||||||||
| 2014-06-30 | 3 | Race Geoff | NERV | Common Stock | D | 346.630 | ||||||||
| 2014-06-30 | 3 | Luthringer Remy By Wint2felden Holding SA | NERV | Common Stock | I | 1.853.208 | ||||||||
| 2014-06-30 | 3 | Luthringer Remy By Wint2felden Holding SA | NERV | Common Stock | I | 1.853.208 | ||||||||
| 2014-06-30 | 3 | Pellegrini Lorenzo See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Pellegrini Lorenzo See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 |
